BHWM
BIO icon

Bay Harbor Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bay Harbor Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$587 Sell
2
-1
-33% -$284 ﹤0.01% 1036
2026
Q1 		$836 Buy
3
+2
+200% +$576 ﹤0.01% 828
2025
Q4 		$302 Hold
1
– – ﹤0.01% 1027
2025
Q3 		$280 Hold
1
– – ﹤0.01% 937
2025
Q2 		$241 Buy
+1
New +$236 ﹤0.01% 865

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bay Harbor Wealth Management's BIO Position: Q2 2026 in Review

Bay Harbor Wealth Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 33% in Q2 2026, selling an estimated $284 and leaving 2 shares worth $587. The position accounts for ﹤0.01% of the portfolio, ranked #1036.

Bay Harbor Wealth Management first reported a position in BIO in Q2 2025 and has held it in 5 quarters since. The position peaked at $836 in Q1 2026. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Bay Harbor Wealth Management held 2 shares of Bio-Rad Laboratories Class A worth $587 as of Q2 2026.
  • Bay Harbor Wealth Management sold 1 Bio-Rad Laboratories Class A share in Q2 2026, an estimated $284.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #1036 holding.
  • Bay Harbor Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q2 2025 and has held it in 5 quarters since.
  • Bay Harbor Wealth Management's Bio-Rad Laboratories Class A position peaked at $836 in Q1 2026.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.